Cardiac Sarcoidosis
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Cardiac sarcoidosis group The patients who diagnosed cardiac sarcoidosis. Control group The other heart disease, who didn't diagnosed cardiac sarcoidosis.
Exclusion criteria
Exclusion criteria: We excluded the patients, we couldn't obtain the consent, we couldn't perform endomyocardial biopsy.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Sensitivity of PAB antibody in cardiac sarcoidosis | — |
Secondary
| Measure | Time frame |
|---|---|
| We compared sensitivity and specificity of PAB antibady with cardiac sarcoidosis and the other heart disease. | — |
Countries
Japan